Reed Smith
The CARES Act funding was a lifeline for many health care organizations and life sciences companies, but came with significant attached strings.
Reed Smith
While the life sciences sector has proven more resilient than most, COVID-19 has undoubtedly caused a dramatic slowdown in deal activity globally across industries.